These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9515950)

  • 41. Italian genomics boost retained.
    Abbott A
    Nature; 2000 May; 405(6783):108-9. PubMed ID: 10821241
    [No Abstract]   [Full Text] [Related]  

  • 42. Startups hope federal study fixes SBIR flaws.
    Basu P
    Nat Biotechnol; 2004 Jun; 22(6):644. PubMed ID: 15175671
    [No Abstract]   [Full Text] [Related]  

  • 43. Biotech project in turmoil as Michigan balances books.
    Knight J
    Nature; 2003 Mar; 422(6928):102. PubMed ID: 12634742
    [No Abstract]   [Full Text] [Related]  

  • 44. Michigan plans massive investment in biotech.
    Kaiser J
    Science; 1999 Jul; 285(5427):502-3. PubMed ID: 10447475
    [No Abstract]   [Full Text] [Related]  

  • 45. Biotech boom.
    Jayaraman KS
    Nat Biotechnol; 2005 Sep; 23(9):1183-4. PubMed ID: 16151411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Special: biotech in Russia.
    Rabinovich M; Burghardt N; Gorzka G; Kudryashev M; Leonov A; Konov A
    Biotechnol J; 2007 Jul; 2(7):775-89. PubMed ID: 17615597
    [No Abstract]   [Full Text] [Related]  

  • 47. U.S. research funding. Physical sciences need boost, advisory panel tells Bush.
    Malakoff D
    Science; 2002 Sep; 297(5587):1622. PubMed ID: 12215613
    [No Abstract]   [Full Text] [Related]  

  • 48. State stem cell initiatives. Most state stem cell efforts staying afloat.
    Holden C
    Science; 2009 Mar; 323(5922):1660-1. PubMed ID: 19325092
    [No Abstract]   [Full Text] [Related]  

  • 49. Chasing biotech across Europe.
    Nasto B
    Nat Biotechnol; 2008 Mar; 26(3):283-8. PubMed ID: 18327234
    [No Abstract]   [Full Text] [Related]  

  • 50. Danish biotech centre faces axe.
    Abbott A
    Nature; 2003 Mar; 422(6928):105. PubMed ID: 12634749
    [No Abstract]   [Full Text] [Related]  

  • 51. Bush's budget boost puts NIH on target for doubled figures.
    Check E
    Nature; 2002 Jan; 415(6871):459. PubMed ID: 11823811
    [No Abstract]   [Full Text] [Related]  

  • 52. Biotech marks time in Q3.
    Lawrence S
    Nat Biotechnol; 2005 Nov; 23(11):1332. PubMed ID: 16273049
    [No Abstract]   [Full Text] [Related]  

  • 53. India. New rules push researchers closer to biotech industry.
    Mudur G
    Science; 1995 Jul; 269(5222):297-8. PubMed ID: 7618096
    [No Abstract]   [Full Text] [Related]  

  • 54. Biotechnology. Stem cells lose market luster.
    Vogel G
    Science; 2003 Mar; 299(5614):1830-1. PubMed ID: 12649456
    [No Abstract]   [Full Text] [Related]  

  • 55. Biotech sector ponders potential 'bloodbath'.
    Mitchell P
    Nat Biotechnol; 2009 Jan; 27(1):3-4. PubMed ID: 19131974
    [No Abstract]   [Full Text] [Related]  

  • 56. Basic and applied research in India: present and future.
    Ramasami T; Rao AV; Natesh S
    Biotechnol J; 2009 Mar; 4(3):301-5. PubMed ID: 19296436
    [No Abstract]   [Full Text] [Related]  

  • 57. Under new management.
    Macilwain C
    Nature; 2001 Dec 20-27; 414(6866):839. PubMed ID: 11780025
    [No Abstract]   [Full Text] [Related]  

  • 58. The promise of South African biotech.
    Akermann B; Kermani F
    Drug Discov Today; 2006 Nov; 11(21-22):962-5. PubMed ID: 17055404
    [No Abstract]   [Full Text] [Related]  

  • 59. Overview of FY 2001 federal budget request.
    Fox JL
    Nat Biotechnol; 2000 Mar; 18(3):259. PubMed ID: 10700131
    [No Abstract]   [Full Text] [Related]  

  • 60. Overview of FY 2000 US federal budget request.
    Fox JL
    Nat Biotechnol; 1999 Mar; 17(3):219. PubMed ID: 10096278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.